A single-center observational study of the characterization of retinal pathologies

Brief description of study

The purpose of the research is to characterize and evaluate retinal pathologies (eye diseases) using eye imaging devices called optical coherence tomography (OCTs). These devices collect images of the eye and are used to diagnosis and monitor eye diseases such as age-related macular degeneration, diabetic retinopathy, macular edema, glaucoma, and other pathologies. This research study will be broken down into two groups of participants— cross-sectional and longitudinal arms. Both the cross-sectional and longitudinal groups will help to characterize retinal pathologies using OCT technology. If you are able to continue participation in this study over the course of multiple visits, you will be in the longitudinal group. If you can only attend one visit, you will be in the cross-sectional group. Two imaging devices that are approved by the Food and Drug Administration (FDA) (Cirrus OCT, Spectralis OCT) and three devices that are not approved by the FDA: Swept Source (SS)-OCT, Adaptive Optics (AO)-OCT, and Visible light (vis)-OCT will be used in the study. The devices that are not FDA-approved are considered experimental.




If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.